Ameliorative effects of ginseng and ginsenosides on rheumatic diseases

Janeway, 2002, Innate immune recognition, Annu Rev Immunol, 20, 197, 10.1146/annurev.immunol.20.083001.084359 Yi, 2016, Folate receptor-targeted diagnostics and therapeutics for inflammatory diseases, Immune Netw, 16, 337, 10.4110/in.2016.16.6.337 Yi, 2017, Caspase-11 non-canonical inflammasome: a critical sensor of intracellular lipopolysaccharide in macrophage-mediated inflammatory responses, Immunology, 152, 207, 10.1111/imm.12787 Yi, 2018, Role of inflammasomes in inflammatory autoimmune rheumatic diseases, Korean J Physiol Pharmacol, 22, 1, 10.4196/kjpp.2018.22.1.1 Kim, 2017, Role of ginsenosides, the main active components of Panax ginseng, in inflammatory responses and diseases, J Ginseng Res, 41, 435, 10.1016/j.jgr.2016.08.004 Chong, 1988, Ginseng–is there a use in clinical medicine?, Postgrad Med J, 64, 841, 10.1136/pgmj.64.757.841 Yun, 2001, Brief introduction of Panax ginseng C.A. Meyer, J Korean Med Sci., 16, S3, 10.3346/jkms.2001.16.S.S3 Deng, 2017, Protopanaxadiol and protopanaxatriol-type saponins ameliorate glucose and lipid metabolism in type 2 diabetes mellitus in high-fat diet/streptozocin-induced mice, Front Pharmacol, 8, 506, 10.3389/fphar.2017.00506 Jiang, 2014, Effects of compound K on hyperglycemia and insulin resistance in rats with type 2 diabetes mellitus, Fitoterapia, 95, 58, 10.1016/j.fitote.2014.02.017 Zhao, 2015, Effect of panax notoginseng saponins injection on the p38MAPK pathway in lung tissue in a rat model of hypoxic pulmonary hypertension, Chin J Integr Med, 21, 147, 10.1007/s11655-014-1790-2 Lee, 2017, Ginseng for treating hypertension: a systematic review and meta-analysis of double blind, randomized, placebo-controlled trials, Curr Vasc Pharmacol, 15, 549, 10.2174/1570161115666170713092701 Yu, 2016, Ginsenoside Rc from Korean red ginseng (panax ginseng C.A. Meyer) attenuates inflammatory symptoms of gastritis, hepatitis and arthritis, Am J Chin Med, 44, 595, 10.1142/S0192415X16500336 Lee, 2017, Protective effects of red ginseng oil against abeta25-35-induced neuronal apoptosis and inflammation in PC12 cells, Int J Mol Sci, 18, 10.3390/ijms18102218 Ong, 2015, Protective effects of ginseng on neurological disorders, Front Aging Neurosci, 7, 129, 10.3389/fnagi.2015.00129 Ahn, 2016, Antinociceptive effects of ginsenoside Rg3 in a rat model of incisional pain, Eur Surg Res, 57, 211, 10.1159/000448001 Kim, 2014, Antihyperalgesic effects of ginseng total saponins in a rat model of incisional pain, J Surg Res, 187, 169, 10.1016/j.jss.2013.09.034 Osada-Oka, 2018, Red ginseng extracts attenuate skin inflammation in atopic dermatitis through p70 ribosomal protein S6 kinase activation, J Pharmacol Sci, 136, 9, 10.1016/j.jphs.2017.11.002 Wang, 2016, Red ginseng and cancer treatment, Chin J Nat Med, 14, 7, 10.1186/s13020-019-0231-3 Dai, 2017, Ginseng on cancer: potential role in modulating inflammation-mediated angiogenesis, Am J Chin Med, 45, 13, 10.1142/S0192415X17500021 Gillis, 1997, Panax ginseng pharmacology: a nitric oxide link?, Biochem Pharmacol, 54, 1, 10.1016/S0006-2952(97)00193-7 Attele, 1999, Ginseng pharmacology: multiple constituents and multiple actions, Biochem Pharmacol, 58, 1685, 10.1016/S0006-2952(99)00212-9 Hasegawa, 2004, Proof of the mysterious efficacy of ginseng: basic and clinical trials: metabolic activation of ginsenoside: deglycosylation by intestinal bacteria and esterification with fatty acid, J Pharmacol Sci, 95, 153, 10.1254/jphs.FMJ04001X4 Liu, 1992, Recent advances on ginseng research in China, J Ethnopharmacol, 36, 27, 10.1016/0378-8741(92)90057-X Sun, 2016, Roles and mechanisms of ginsenoside in cardiovascular diseases: progress and perspectives, Sci China Life Sci, 59, 292, 10.1007/s11427-016-5007-8 Lee, 2014, A review on the medicinal potentials of ginseng and ginsenosides on cardiovascular diseases, J Ginseng Res, 38, 161, 10.1016/j.jgr.2014.03.001 Yuan, 2012, Ginseng and diabetes: the evidences from in vitro, animal and human studies, J Ginseng Res, 36, 27, 10.5142/jgr.2012.36.1.27 Zhang, 2017, Ginseng and obesity: observations and understanding in cultured cells, animals and humans, J Nutr Biochem, 44, 1, 10.1016/j.jnutbio.2016.11.010 Sabouri-Rad, 2017, Ginseng in dermatology: a review, Curr Pharm Des, 23, 1649, 10.2174/1381612822666161021152322 Sodrul, 2018, Role of ginsenosides in reactive oxygen species-mediated anticancer therapy, Oncotarget, 9, 2931, 10.18632/oncotarget.23407 Chen, 2016, Anticancer activities of protopanaxadiol- and protopanaxatriol-type ginsenosides and their metabolites, Evid Based Complement Alternat Med, 2016, 5738694, 10.1155/2016/5738694 Smolen, 2018, Rheumatoid arthritis, Nat Rev Dis Primers, 4, 18001, 10.1038/nrdp.2018.1 Yi, 2009, Folate-targeted hapten immunotherapy of adjuvant-induced arthritis: comparison of hapten potencies, Mol Pharm, 6, 1228, 10.1021/mp900070b Myasoedova, 2010, Is the incidence of rheumatoid arthritis rising?: results from Olmsted County, Minnesota, 1955-2007, Arthritis Rheum, 62, 1576, 10.1002/art.27425 Tobon, 2010, The environment, geo-epidemiology, and autoimmune disease: rheumatoid arthritis, J Autoimmun, 35, 10, 10.1016/j.jaut.2009.12.009 Szekanecz, 2007, Macrophages and their products in rheumatoid arthritis, Curr Opin Rheumatol, 19, 289, 10.1097/BOR.0b013e32805e87ae Choi, 2013, Joint-protective effects of compound K, a major ginsenoside metabolite, in rheumatoid arthritis: in vitro evidence, Rheumatol Int, 33, 1981, 10.1007/s00296-013-2664-9 Kim, 2007, Anti-arthritic effect of ginsenoside Rb1 on collagen induced arthritis in mice, Int Immunopharmacol, 7, 1286, 10.1016/j.intimp.2007.05.006 Chang, 2007, Anti-inflammatory effects of BT-201, an n-butanol extract of Panax notoginseng, observed in vitro and in a collagen-induced arthritis model, Clin Nutr, 26, 785, 10.1016/j.clnu.2007.07.008 Zhang, 2007, Clinical study on effect of total panax notoginseng saponins on immune related inner environment imbalance in rheumatoid arthritis patients, Zhongguo Zhong Xi Yi Jie He Za Zhi, 27, 589 Heidari, 2011, Knee osteoarthritis prevalence, risk factors, pathogenesis and features: Part I, Caspian J Intern Med, 2, 205 Zhang, 2010, Epidemiology of osteoarthritis, Clin Geriatr Med, 26, 355, 10.1016/j.cger.2010.03.001 Brandt, 2009, Etiopathogenesis of osteoarthritis, Med Clin North Am., 93, 1, 10.1016/j.mcna.2008.08.009 Evans, 2018, Gene delivery to joints by intra-articular injection, Hum Gene Ther, 29, 2, 10.1089/hum.2017.181 Madry, 2016, Gene therapy for human osteoarthritis: principles and clinical translation, Expert Opin Biol Ther, 16, 331, 10.1517/14712598.2016.1124084 Zhang, 2007, Amelioration of osteoarthritis by intra-articular hyaluronan synthase 2 gene therapy, Med Hypotheses, 69, 1111, 10.1016/j.mehy.2007.01.084 Mason, 2017, Wnt10b and Dkk-1 gene therapy differentially influenced trabecular bone architecture, soft tissue integrity, and osteophytosis in a skeletally mature rat model of osteoarthritis, Connect Tissue Res., 58, 542, 10.1080/03008207.2016.1267153 Noh, 2015, Orthopedic cellular therapy: an overview with focus on clinical trials, World J Orthop, 6, 754, 10.5312/wjo.v6.i10.754 Prasadam, 2018, Mixed cell therapy of bone marrow-derived mesenchymal stem cells and articular cartilage chondrocytes ameliorates osteoarthritis development, Lab Invest, 98, 106, 10.1038/labinvest.2017.117 McIntyre, 2017, Intra-articular mesenchymal stem cell therapy for the human joint: a systematic review, Am J Sports Med Deng, 2015, Cell therapy with g-CSF-mobilized stem cells in a rat osteoarthritis model, Cell Transplant, 24, 1085, 10.3727/096368914X680091 Kang, 2016, Therapeutic potential of compound K as an IKK inhibitor with implications for osteoarthritis prevention: an in silico and in vitro study, In Vitro Cell Dev Biol Anim, 52, 895, 10.1007/s11626-016-0062-9 So, 2013, Protective effects of ginsenoside Rg3 on human osteoarthritic chondrocytes, Mod Rheumatol, 23, 104, 10.3109/s10165-012-0635-8 Karlsson, 2008, Notch1, Jagged1, and HES5 are abundantly expressed in osteoarthritis, Cells Tissues Organs, 188, 287, 10.1159/000121610 Wang, 2015, Ginsenoside Rb1 inhibits matrix metalloproteinase 13 through down-regulating Notch signaling pathway in osteoarthritis, Exp Biol Med (Maywood), 240, 1614, 10.1177/1535370215587918 Zhang, 2017, GinsenosideRg5 treatment inhibits apoptosis of chondrocytes and degradation of cartilage matrix in a rat model of osteoarthritis, Oncol Rep, 37, 1497, 10.3892/or.2017.5392 Cheng, 2017, Chondroprotective effects of ginsenoside Rg1 in human osteoarthritis chondrocytes and a rat model of anterior cruciate ligament transection, Nutrients, 9 Arbuckle, 2003, Development of autoantibodies before the clinical onset of systemic lupus erythematosus, N Engl J Med, 349, 1526, 10.1056/NEJMoa021933 Yi, 2016, Functional role of milk fat globule-epidermal growth factor VIII in macrophage-mediated inflammatory responses and inflammatory/autoimmune diseases, Mediators Inflamm, 2016, 5628486, 10.1155/2016/5628486 Rees, 2016, The incidence and prevalence of systemic lupus erythematosus in the UK, 1999-2012, Ann Rheum Dis, 75, 136, 10.1136/annrheumdis-2014-206334 Rees, 2017, The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies, Rheumatology (Oxford), 56, 1945, 10.1093/rheumatology/kex260 Yildirim-Toruner, 2011, Current and novel therapeutics in the treatment of systemic lupus erythematosus, J Allergy Clin Immunol, 127, 303, 10.1016/j.jaci.2010.12.1087 Yang, 1986, Treatment of systemic lupus erythematosus with saponin of ginseng fruit (SPGF): an immunological study, Zhong Xi Yi Jie He Za Zhi, 6 You, 2009, Efficacy of combined therapy with ginsenosides and prednisone in treating systemic lupus erythematosus–a randomized, controlled and double-blinded trial, Zhongguo Zhong Xi Yi Jie He Za Zhi, 29, 776 You, 2010, Efficacy of ginsenosides combined with prednisone in patients with systemic lupus erythematosus: a prospective, randomized, double-blind, placebo-controlled trial, Zhong Xi Yi Jie He Xue Bao, 8, 762, 10.3736/jcim20100806